Premium
Vitamin D deficiency and myocardial diseases
Author(s) -
Pilz Stefan,
Tomaschitz Andreas,
Drechsler Christiane,
Dekker Jacqueline M.,
März Winfried
Publication year - 2010
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.200900474
Subject(s) - medicine , vitamin d and neurology , vitamin d deficiency , heart failure , vitamin , contractility , calcitriol receptor , endocrinology , rickets , cardiology , physiology
Vitamin D deficiency is common among patients with myocardial diseases because sun‐induced vitamin D production in the skin and dietary intake of vitamin D is often insufficient. Knockout mice for the vitamin D receptor develop myocardial hypertrophy and dysfunction. It has also been shown that children with rickets who suffered from severe heart failure could be successfully treated with supplementation of vitamin D plus calcium. In adults, almost all patients with heart failure exhibit reduced 25‐hydroxyvitamin D levels, which are used to classify the vitamin D status. In prospective studies, vitamin D deficiency was an independent risk factor for mortality, deaths due to heart failure and sudden cardiac death. Several vitamin D effects on the electrophysiology, contractility, and structure of the heart suggest that vitamin D deficiency might be a causal factor for myocardial diseases. Data from interventional trials, however, are rare and urgently needed to elucidate whether vitamin D supplementation is useful for the treatment of myocardial diseases. In our opinion, the current knowledge of the beneficial effects of vitamin D on myocardial and overall health strongly argue for vitamin D supplementation in all vitamin D‐deficient patients with or at high risk for myocardial diseases.